ID   PYRG1_HUMAN             Reviewed;         591 AA.
AC   P17812; B4DR64; D3DPW1; Q5VW67; Q96GK6;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2002, sequence version 2.
DT   12-APR-2017, entry version 184.
DE   RecName: Full=CTP synthase 1 {ECO:0000305};
DE            EC=6.3.4.2 {ECO:0000269|PubMed:16179339, ECO:0000269|PubMed:24870241};
DE   AltName: Full=CTP synthetase 1;
DE   AltName: Full=UTP--ammonia ligase 1;
GN   Name=CTPS1 {ECO:0000312|HGNC:HGNC:2519};
GN   Synonyms=CTPS {ECO:0000312|HGNC:HGNC:2519};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=2113467;
RA   Yamauchi M., Yamauchi N., Meuth M.;
RT   "Molecular cloning of the human CTP synthetase gene by functional
RT   complementation with purified human metaphase chromosomes.";
RL   EMBO J. 9:2095-2099(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-571.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=16179339; DOI=10.1074/jbc.M509622200;
RA   Han G.-S., Sreenivas A., Choi M.-G., Chang Y.-F., Martin S.S.,
RA   Baldwin E.P., Carman G.M.;
RT   "Expression of human CTP synthetase in Saccharomyces cerevisiae
RT   reveals phosphorylation by protein kinase A.";
RL   J. Biol. Chem. 280:38328-38336(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568; SER-571; SER-573;
RP   SER-574; SER-575 AND SER-587, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-571; SER-574 AND
RP   SER-575, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-100, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-574 AND SER-575, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-562; SER-573 AND
RP   SER-575, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-575, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, TISSUE SPECIFICITY, INDUCTION,
RP   AND INVOLVEMENT IN IMD24.
RX   PubMed=24870241; DOI=10.1038/nature13386;
RA   Martin E., Palmic N., Sanquer S., Lenoir C., Hauck F., Mongellaz C.,
RA   Fabrega S., Nitschke P., Esposti M.D., Schwartzentruber J., Taylor N.,
RA   Majewski J., Jabado N., Wynn R.F., Picard C., Fischer A.,
RA   Arkwright P.D., Latour S.;
RT   "CTP synthase 1 deficiency in humans reveals its central role in
RT   lymphocyte proliferation.";
RL   Nature 510:288-292(2014).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-272.
RX   PubMed=16820675; DOI=10.1107/S1744309106018136;
RA   Kursula P., Flodin S., Ehn M., Hammarstrom M., Schuler H.,
RA   Nordlund P., Stenmark P.;
RT   "Structure of the synthetase domain of human CTP synthetase, a target
RT   for anticancer therapy.";
RL   Acta Crystallogr. F 62:613-617(2006).
CC   -!- FUNCTION: This enzyme is involved in the de novo synthesis of CTP,
CC       a precursor of DNA, RNA and phospholipids. Catalyzes the ATP-
CC       dependent amination of UTP to CTP with either L-glutamine or
CC       ammonia as a source of nitrogen. This enzyme and its product, CTP,
CC       play a crucial role in the proliferation of activated lymphocytes
CC       and therefore in immunity. {ECO:0000269|PubMed:16179339,
CC       ECO:0000269|PubMed:24870241}.
CC   -!- CATALYTIC ACTIVITY: ATP + UTP + L-glutamine = ADP + phosphate +
CC       CTP + L-glutamate. {ECO:0000269|PubMed:16179339,
CC       ECO:0000269|PubMed:24870241}.
CC   -!- ENZYME REGULATION: Activated by GTP and inhibited by CTP.
CC   -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via de novo
CC       pathway; CTP from UDP: step 2/2. {ECO:0000269|PubMed:16179339,
CC       ECO:0000269|PubMed:24870241}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-1042983, EBI-1042983;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P17812-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P17812-2; Sequence=VSP_055827;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:24870241}.
CC   -!- INDUCTION: Up-regulated in T-cells and B-cells activated through
CC       the TCR and the BCR respectively (at protein level).
CC       {ECO:0000269|PubMed:24870241}.
CC   -!- DISEASE: Immunodeficiency 24 (IMD24) [MIM:615897]: A life-
CC       threatening immunodeficiency, characterized by an impaired
CC       capacity of activated T and B cells to proliferate in response to
CC       antigen receptor-mediated activation. Patients have early onset of
CC       severe chronic viral infections, mostly caused by herpes viruses,
CC       including EBV and varicella zooster virus (VZV), and also suffer
CC       from recurrent encapsulated bacterial infections, a spectrum of
CC       infections typical of a combined deficiency of adaptive immunity.
CC       {ECO:0000269|PubMed:24870241}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. A unique
CC       and recessive G to C mutation probably affecting a splice donor
CC       site at the junction of intron 17-18 and exon 18 has been
CC       identified in all patients. It results in expression of an
CC       abnormal transcript lacking exon 18 and a complete loss of the
CC       expression of the protein. {ECO:0000269|PubMed:24870241}.
CC   -!- SIMILARITY: Belongs to the CTP synthase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52142; CAA36386.1; -; mRNA.
DR   EMBL; AK299122; BAG61176.1; -; mRNA.
DR   EMBL; AL391730; CAH72797.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07192.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07193.1; -; Genomic_DNA.
DR   EMBL; BC009408; AAH09408.1; -; mRNA.
DR   CCDS; CCDS459.1; -. [P17812-1]
DR   PIR; S12791; SYHUTP.
DR   RefSeq; NP_001288166.1; NM_001301237.1.
DR   RefSeq; NP_001896.2; NM_001905.3. [P17812-1]
DR   UniGene; Hs.473087; -.
DR   PDB; 2VO1; X-ray; 2.80 A; A/B=1-273.
DR   PDBsum; 2VO1; -.
DR   ProteinModelPortal; P17812; -.
DR   SMR; P17812; -.
DR   BioGrid; 107883; 64.
DR   IntAct; P17812; 16.
DR   MINT; MINT-3008801; -.
DR   STRING; 9606.ENSP00000361699; -.
DR   DrugBank; DB00130; L-Glutamine.
DR   MEROPS; C26.A36; -.
DR   iPTMnet; P17812; -.
DR   PhosphoSitePlus; P17812; -.
DR   SwissPalm; P17812; -.
DR   BioMuta; CTPS1; -.
DR   DMDM; 20981706; -.
DR   EPD; P17812; -.
DR   MaxQB; P17812; -.
DR   PaxDb; P17812; -.
DR   PeptideAtlas; P17812; -.
DR   PRIDE; P17812; -.
DR   Ensembl; ENST00000372616; ENSP00000361699; ENSG00000171793. [P17812-1]
DR   Ensembl; ENST00000372621; ENSP00000361704; ENSG00000171793. [P17812-1]
DR   GeneID; 1503; -.
DR   KEGG; hsa:1503; -.
DR   UCSC; uc001cgk.5; human. [P17812-1]
DR   CTD; 1503; -.
DR   DisGeNET; 1503; -.
DR   GeneCards; CTPS1; -.
DR   H-InvDB; HIX0000479; -.
DR   HGNC; HGNC:2519; CTPS1.
DR   HPA; CAB017111; -.
DR   HPA; HPA051322; -.
DR   MalaCards; CTPS1; -.
DR   MIM; 123860; gene.
DR   MIM; 615897; phenotype.
DR   neXtProt; NX_P17812; -.
DR   OpenTargets; ENSG00000171793; -.
DR   PharmGKB; PA27020; -.
DR   eggNOG; KOG2387; Eukaryota.
DR   eggNOG; COG0504; LUCA.
DR   GeneTree; ENSGT00390000012473; -.
DR   HOGENOM; HOG000077514; -.
DR   HOVERGEN; HBG002243; -.
DR   InParanoid; P17812; -.
DR   KO; K01937; -.
DR   OMA; SCSERHR; -.
DR   OrthoDB; EOG091G03OK; -.
DR   PhylomeDB; P17812; -.
DR   TreeFam; TF300379; -.
DR   BioCyc; MetaCyc:HS10382-MONOMER; -.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   SIGNOR; P17812; -.
DR   UniPathway; UPA00159; UER00277.
DR   EvolutionaryTrace; P17812; -.
DR   GeneWiki; CTP_synthase_1; -.
DR   GenomeRNAi; 1503; -.
DR   PRO; PR:P17812; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000171793; -.
DR   CleanEx; HS_CTPS; -.
DR   Genevisible; P17812; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003883; F:CTP synthase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044210; P:'de novo' CTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0042100; P:B cell proliferation; IMP:UniProtKB.
DR   GO; GO:0006241; P:CTP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; TAS:ProtInc.
DR   GO; GO:0042098; P:T cell proliferation; IMP:UniProtKB.
DR   CDD; cd01746; GATase1_CTP_Synthase; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   HAMAP; MF_01227; PyrG; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR004468; CTP_synthase.
DR   InterPro; IPR017456; CTP_synthase_N.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR033828; GATase1_CTP_Synthase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11550; PTHR11550; 1.
DR   Pfam; PF06418; CTP_synth_N; 1.
DR   Pfam; PF00117; GATase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00337; PyrG; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Glutamine amidotransferase; Immunity; Ligase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Pyrimidine biosynthesis; Reference proteome.
FT   CHAIN         1    591       CTP synthase 1.
FT                                /FTId=PRO_0000138275.
FT   DOMAIN      300    554       Glutamine amidotransferase type-1.
FT   ACT_SITE    399    399       For GATase activity. {ECO:0000250}.
FT   ACT_SITE    526    526       For GATase activity. {ECO:0000250}.
FT   ACT_SITE    528    528       For GATase activity. {ECO:0000250}.
FT   MOD_RES     100    100       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     562    562       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     568    568       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     571    571       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     573    573       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     574    574       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     575    575       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     578    578       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70698}.
FT   MOD_RES     587    587       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1    231       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055827.
FT   VARIANT     571    571       S -> I (in dbSNP:rs17856308).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027055.
FT   CONFLICT    305    305       G -> A (in Ref. 1; CAA36386).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       K -> E (in Ref. 1; CAA36386).
FT                                {ECO:0000305}.
FT   STRAND        2      8       {ECO:0000244|PDB:2VO1}.
FT   STRAND       10     15       {ECO:0000244|PDB:2VO1}.
FT   HELIX        16     29       {ECO:0000244|PDB:2VO1}.
FT   STRAND       34     40       {ECO:0000244|PDB:2VO1}.
FT   STRAND       87     89       {ECO:0000244|PDB:2VO1}.
FT   HELIX        90    102       {ECO:0000244|PDB:2VO1}.
FT   TURN        103    108       {ECO:0000244|PDB:2VO1}.
FT   HELIX       113    130       {ECO:0000244|PDB:2VO1}.
FT   STRAND      134    136       {ECO:0000244|PDB:2VO1}.
FT   STRAND      141    147       {ECO:0000244|PDB:2VO1}.
FT   HELIX       154    156       {ECO:0000244|PDB:2VO1}.
FT   HELIX       157    169       {ECO:0000244|PDB:2VO1}.
FT   HELIX       172    174       {ECO:0000244|PDB:2VO1}.
FT   STRAND      175    182       {ECO:0000244|PDB:2VO1}.
FT   HELIX       195    207       {ECO:0000244|PDB:2VO1}.
FT   STRAND      212    217       {ECO:0000244|PDB:2VO1}.
FT   HELIX       224    233       {ECO:0000244|PDB:2VO1}.
FT   HELIX       238    240       {ECO:0000244|PDB:2VO1}.
FT   STRAND      241    244       {ECO:0000244|PDB:2VO1}.
FT   HELIX       250    252       {ECO:0000244|PDB:2VO1}.
FT   HELIX       253    259       {ECO:0000244|PDB:2VO1}.
FT   HELIX       262    270       {ECO:0000244|PDB:2VO1}.
SQ   SEQUENCE   591 AA;  66690 MW;  0B04F9D9390C4152 CRC64;
     MKYILVTGGV ISGIGKGIIA SSVGTILKSC GLHVTSIKID PYINIDAGTF SPYEHGEVFV
     LDDGGEVDLD LGNYERFLDI RLTKDNNLTT GKIYQYVINK ERKGDYLGKT VQVVPHITDA
     IQEWVMRQAL IPVDEDGLEP QVCVIELGGT VGDIESMPFI EAFRQFQFKV KRENFCNIHV
     SLVPQPSSTG EQKTKPTQNS VRELRGLGLS PDLVVCRCSN PLDTSVKEKI SMFCHVEPEQ
     VICVHDVSSI YRVPLLLEEQ GVVDYFLRRL DLPIERQPRK MLMKWKEMAD RYDRLLETCS
     IALVGKYTKF SDSYASVIKA LEHSALAINH KLEIKYIDSA DLEPITSQEE PVRYHEAWQK
     LCSAHGVLVP GGFGVRGTEG KIQAIAWARN QKKPFLGVCL GMQLAVVEFS RNVLGWQDAN
     STEFDPTTSH PVVVDMPEHN PGQMGGTMRL GKRRTLFQTK NSVMRKLYGD ADYLEERHRH
     RFEVNPVWKK CLEEQGLKFV GQDVEGERME IVELEDHPFF VGVQYHPEFL SRPIKPSPPY
     FGLLLASVGR LSHYLQKGCR LSPRDTYSDR SGSSSPDSEI TELKFPSINH D
//
